Clinical efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis

Assess the effectiveness and safety of treatment options atezolizumab plus bevacizumab (Atez/Bev) or lenvatinib in clinical practice for patients with advanced hepatocellular carcinoma (HCC) patients. METHODS: To compare the effectiveness of Atez/Bev and lenvatinib in treating advanced HCC, we syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Sihao, Cao, Ke, Wang, Zhenshun, Lin, Dongdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256357/
https://www.ncbi.nlm.nih.gov/pubmed/37335628
http://dx.doi.org/10.1097/MD.0000000000033852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256357/
https://www.ncbi.nlm.nih.gov/pubmed/37335628
http://dx.doi.org/10.1097/MD.0000000000033852

Ejemplares similares